NEPHROS, INC. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
NEPHROS, INC. (NEPH) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of -$1.43 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2024-03-15
- NEPHROS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2022-12-31 was -$129.00K.
- NEPHROS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2022-09-30 was -$509.00K.
- NEPHROS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2022-06-30 was -$390.00K.
- NEPHROS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2022-03-31 was -$406.00K.
- NEPHROS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2022 was -$1.43M.
- NEPHROS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2021 was -$1.08M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 6 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$638.00K derived: sum of 2 quarters · filed 2024-03-15 | -$1.03M derived: sum of 3 quarters · filed 2024-03-15 | -$1.43M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$509.00K 10-Q · filed 2023-11-08 | -$899.00K derived: sum of 2 quarters · filed 2023-11-08 | -$1.30M 10-Q · filed 2023-11-08 | -$1.62M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$390.00K 10-Q · filed 2023-08-09 | -$796.00K 10-Q · filed 2023-08-09 | -$1.11M derived: sum of 3 quarters · filed 2023-08-09 | -$1.47M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$406.00K 10-Q · filed 2023-05-10 | -$723.00K derived: sum of 2 quarters · filed 2023-05-10 | -$1.08M derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$677.00K derived: sum of 2 quarters · filed 2023-03-23 | -$1.08M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$360.00K 10-Q · filed 2022-11-15 | -$766.00K 10-Q · filed 2022-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |